Nano-crystalline Megestrol Acetate Oral Suspension
Megaxia ES-SCLC
Phase 3 small_molecule active
Quick answer
Nano-crystalline Megestrol Acetate Oral Suspension for Extensive-stage Small Cell Lung Cancer (ES-SCLC) is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Extensive-stage Small Cell Lung Cancer (ES-SCLC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active